Pivotal Phase 3 Topline Results for Neuromuscular-Targeting OSA Drug Candidate
A 12-month study evaluated the efficacy and safety of the drug candidate in adults with mild, moderate, and severe OSA.
Read MoreA 12-month study evaluated the efficacy and safety of the drug candidate in adults with mild, moderate, and severe OSA.
Read MoreResearchers in Canada surveyed 1,082 university students about their eating habits, sleep patterns and dreams. Remarkably, 40% reported that certain foods affected their sleep.
Read MoreWhen scientists measure sleep objectively, such as via an EEGvto assess brain waves, the data actually shows poorer sleep quality when co-sleeping.
Read MoreYou might have heard cannabis and cannabinoid products can help people sleep.
Read MoreA key caveat is that individual sleep needs vary considerably.
Read More